Influence of aging on serum cholesterol levels in heterozygous familial hypercholesterolemia patients with long-term LDL apheresis therapy

被引：0
|
作者：
Miwa, K
Toudou, Y
Kawashiri, M
Higashikata, T
Inazu, A
Koizumi, J
Mabuchi, H
机构：
[1] Kanazawa Univ, Grad Sch, Kanazawa, Ishikawa 920, Japan
[2] Kanazawa Univ, Grad Sch Hlth Sci, Kanazawa, Ishikawa 920, Japan
[3] Kanazawa Univ, Dept Gen Med, Kanazawa, Ishikawa 920, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)90747-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF LONG-TERM LDL-C LOWERING ON ATHEROSCLEROSIS IN ADULTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Sivapalaratnam, S.
    van Loendersloot, L.
    Hutten, B.
    Trip, M.
    Kastelein, J.
    de Groot, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [22] LONG-TERM RESULT OF LDL SELECTIVE PLASMA ADSORPTION THERAPY ON FAMILIAL HYPERCHOLESTEROLEMIA
    ODAKA, M
    KOBAYASHI, H
    TABATA, Y
    SOEDA, K
    HAYASHI, H
    ITO, S
    MUROTANI, N
    SAITO, Y
    NISHIDE, T
    SHINOMIYA, M
    YOSHIDA, S
    BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1987, 15 (01): : 113 - 124
  • [23] Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
    Viktória E. Varga
    Hajnalka Lőrincz
    Noémi Zsíros
    Péter Fülöp
    Ildikó Seres
    György Paragh
    József Balla
    Mariann Harangi
    Lipids in Health and Disease, 15
  • [24] Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
    Varga, Viktoria E.
    Lorincz, Hajnalka
    Zsiros, Noemi
    Fulop, Peter
    Seres, Ildiko
    Paragh, Gyorgy
    Balla, Jozsef
    Harangi, Mariann
    LIPIDS IN HEALTH AND DISEASE, 2016, 15 : 1 - 7
  • [25] LONG-TERM EXPERIENCE (6 YEARS) WITH SIMVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    KNOPS, RE
    KROON, AA
    MOL, MJTM
    STUYT, PMJ
    STALENHOEF, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (04): : 171 - 178
  • [26] Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia
    Hovingh, G. Kees
    Raal, Frederick J.
    Dent, Ricardo
    Stefanutti, Claudia
    Descamps, Olivier
    Masana, Luis
    Lira, Armando
    Bridges, Ian
    Coll, Blai
    Sullivan, David
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (06) : 1448 - 1457
  • [27] Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy
    Hartgers, Merel L.
    Besseling, Joost
    Stroes, Erik S.
    Wittekoek, Janneke
    Rutten, Joost H. W.
    de Graaf, Jacqueline
    Visseren, Frank L. J.
    Imholz, Ben P. M.
    van Lennep, Jeanine E. Roeters
    Huijgen, Roeland
    Kastelein, John J. P.
    Hovingh, G. Kees
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) : 972 - 980
  • [28] LONG-TERM EFFICACY AND SAFETY OF LERODALCIBEP IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Raal, Frederick J.
    Scott, Russell
    Blom, Dirk
    Kayikcioglu, Meral
    Kallend, David
    Stein, Evan A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1704 - 1704
  • [29] Ldl-receptor genotype dependent response to cholesterol-lowering therapy in patients with heterozygous familial hypercholesterolemia
    Kajinami, K
    Yagi, K
    Higashikata, T
    Inazu, A
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 56 - 56
  • [30] SHORT-TERM AND LONG-TERM EFFECTS OF LDL-APHERESIS ON LIPOPROTEIN(A) SERUM LEVELS
    RITTER, MM
    SUHLER, K
    RICHTER, W
    SCHWANDT, P
    CLINICA CHIMICA ACTA, 1990, 195 (1-2) : 9 - 15
12345